Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.83
28.04.24
-
28.04.25
8.96%
13.05.24

buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.43
28.04.24
-
28.04.25
11.19%
13.05.24

buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€2.60
09.05.24
-
09.05.25
-29.60%
13.05.24

Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€4.30
02.05.24
-
02.05.25
-57.47%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
Stantec Inc.

Start price
Target price
Perf. (%)
€54.00
12.05.23
-
12.05.24
37.04%
13.05.24

buy
Atos SE

Start price
Target price
Perf. (%)
€12.62
12.05.23
-
12.05.24
-83.64%
13.05.24

buy
Atos SE

Start price
Target price
Perf. (%)
€12.62
12.05.23
-
12.05.24
-83.64%
13.05.24

buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€81.98
12.05.23
-
12.05.24
-1.24%
13.05.24

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.81
07.05.24
-
07.05.25
-51.97%
12.05.24

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€9.37
10.05.24
-
10.05.25
-7.12%
12.05.24

buy
Arista Networks

Start price
Target price
Perf. (%)
€266.90
02.03.24
€266.00
02.03.25
9.12%
12.05.24

buy
Knorr-Bremse AG

Start price
Target price
Perf. (%)
€70.62
26.03.24
€72.00
26.03.25
5.92%
12.05.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Vonovia SE

Start price
Target price
Perf. (%)
€25.86
27.04.24
€27.00
27.04.25
7.19%
12.05.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.42
03.05.24
€4.00
03.05.25
96.81%
12.05.24

buy
TeamViewer AG

Start price
Target price
Perf. (%)
€14.93
07.02.24
€16.00
07.02.25
-21.34%
12.05.24

Innovative
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected